GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genelink GNLKQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2012

Revenue

$2.1m

FY2012FY2012

Net income

−$3.1m

FY2012FY2012

Free cash flow

−$2.6m

FY2012FY2012

Shareholders' equity

−$2.7m

FY2012FY2012

Income statement

Fiscal years

FY2012
Revenue$2.1m
Gross profit$464,683
Research and development$250,808
Operating income−$3.5m
Net income−$3.1m
Diluted earnings per share-0.01

Balance sheet

At each fiscal year end

FY2012
Total assets$1.5m
Cash and short-term investments$158,468
Total liabilities$4.1m
Debt$2.2m
Shareholders' equity−$2.7m
Shares outstanding234m

Cash flow

Fiscal years

FY2012
Cash from operations−$2.4m
Capital spending−$241,966
Free cash flow−$2.6m

Latest quarters

By quarter end

Sept 2013Jun 2013Mar 2013Dec 2012Sept 2012Jun 2012Mar 2012Dec 2011
Revenue$294,739$621,922$399,896$412,482$425,073$526,923$771,664$881,703
Gross profit$72,506$308,990$92,355−$17,449−$89,749$138,420$433,461$550,909
Operating income−$603,317−$240,257−$357,423−$1.0m−$892,040−$765,733−$788,468−$1.5m
Net income−$539,292−$325,137−$353,771−$1.0m−$974,386−$962,630−$105,673−$1.5m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.01
Total assets$1.3m$1.3m$1.2m$1.5m$2.7m$2.1m$2.7m$2.8m
Cash and short-term investments$127,559$1,443$11,414$158,468$977,456$65,977$635,540$740,769
Debt$2.4m$2.3m$2.2m$2.2m————
Shareholders' equity−$3.2m−$3.1m−$3.0m−$2.7m−$2.9m−$2.3m−$1.5m−$1.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-37.0%85.3%42.1%
Operating income12.1%22.3%12.4%
Net income4.0%14.4%7.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.1%57.3%60.2%60.1%
Operating margin-103.2%-51.2%-51.9%-70.9%
Net margin-100.9%-52.7%-55.2%-74.2%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%0%7697645%144346735732%7539292%1179650%685043%8150%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.